Tanya Lewis - Insider Trading & Ownership

Location
C/O Karyopharm Therapeutics Inc., 85 Wells Ave., Newton, MA
Summary
The estimated net worth of Tanya Lewis is at least $1.48M dollars as of June 3, 2025. Tanya Lewis is the Chief Dev. Op. Officer of Replimune Group, Inc. and owns shares of Replimune Group, Inc. (REPL) stock worth about $1.48M.
Signature
/s/ Scott Kellen, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Tanya Lewis

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
REPL Replimune Group, Inc. Chief Dev. Op. Officer $1.48M Jun 13, 2023
DMAC DiaMedica Therapeutics Inc. Director $0 Jun 1, 2025

Insider Transactions Reported by Tanya Lewis:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.